Biotech Acquisition Company (BIOT)
BIOT has a market cap or net worth of $284.62 million. The enterprise value is $284.64 million.
BIOT has 28.75 million shares outstanding. The number of shares has increased by 34.59% in one year.
|Shares Change (YoY)||+34.59%|
|Shares Change (QoQ)||-0.07%|
|Owned by Insiders (%)||n/a|
|Owned by Institutions (%)||111.53%|
|EV / Earnings||n/a|
|EV / Sales||n/a|
|EV / EBITDA||n/a|
|EV / EBIT||n/a|
|EV / FCF||n/a|
The company has a current ratio of 0.14, with a Debt / Equity ratio of n/a.
|Debt / Equity||n/a|
|Debt / EBITDA||n/a|
|Debt / FCF||n/a|
|Return on Equity (ROE)||n/a|
|Return on Assets (ROA)||-2.10%|
|Return on Capital (ROIC)||-2.10%|
|Revenue Per Employee||n/a|
|Profits Per Employee||-$1.18M|
|Effective Tax Rate||n/a|
Stock Price Statistics
|Total Price Change||+2.06%|
|50-Day Moving Average||9.75|
|200-Day Moving Average||9.83|
|Average Volume (30 Days)||157,168|
Short Selling Information
The latest short interest is 153,258, so 0.53% of the outstanding shares have been sold short.
|Short % of Shares Out||0.53%|
|Short % of Float||0.73%|
|Short Ratio (days to cover)||0.78|
|Earnings Per Share (EPS)||-$0.17|
The company has $104,056 in cash and $115,850 in debt, giving a net cash position of -$11,794 or $0.00 per share.
|Cash & Cash Equivalents||104,056|
|Net Cash Per Share||$0.00|
|Book Value Per Share||-0.78|
|Operating Cash Flow||-702,826|
|Free Cash Flow||-702,826|
|FCF Per Share||n/a|
Dividends & Yields
BIOT does not appear to pay any dividends at this time.
|Dividend Per Share||n/a|
|Dividend Growth (YoY)||n/a|
|Price Target Difference||n/a|
The last stock split was on August 9, 2010. It was a reverse split with a ratio of 1:0.
|Last Split Date||Aug 9, 2010|